STAAR Surgical Company
NASDAQStifel just flipped to Buy on STAA. The upgrade comes with a $31 target — 49% above Monday's close of $20.87. Short sellers have been heading for the exits at the same time. Stifel analyst Thomas Stephan raised his rating from Hold to Buy this morning. His new $31 target is up from $28. The timing stands out: Stephan had cut his target to $28 in August…
STAA upgraded to Buy by Stifel with $31 target, implying 49% upside from current $20.87 level; short interest at 7.5% of float, down 22% over past week.
Snapshot as of 29 Sept 2026
Stifel just flipped to Buy on STAA. The upgrade comes with a $31 target — 49% above Monday's close of $20.87. Short sellers have been heading for the exits at the same time. Stifel analyst Thomas Stephan raised his…
STAA heads into its August 12 earnings report with a notable gap opening between where options traders are leaning and where short sellers are sitting. The sharpest signal this week is in options. The put/call ratio…
STAA is trading above every analyst's published price target — a sign that the stock has moved faster than Wall Street's models anticipated, and that the heavy short interest has not been enough to hold it back. The…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for STAA — free to start on ORTEX.
Sign up for free →Open STAA on ORTEX